Cystic FibrosisNCT05963503
Predictors of Health Literacy in Adults With Cystic Fibrosis
An observational study of Cystic Fibrosis, run by Hacettepe University at 1 site in Turkey (Türkiye).
Trial summary
The purpose of this study investigation of relationship between health literacy and physical activity, anxiety and depression, adherence to airway clearance techniques in adult patients with cystic fibrosis. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Cystic Fibrosis
- What is being tested?
- Assessments
- How many people
- 62 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Aug 2023to 15 Aug 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Cystic fibrosis participants between 18-65 years old.
Who may be able to join
- be between the ages of 18-65 volunteering to participate
Who cannot join
- having any cardiopulmonary disease having cognitive problems being illiterate
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study investigation of relationship between health literacy and physical activity, anxiety and depression, adherence to airway clearance techniques in adult patients with cystic fibrosis.
Read the detailed description
The assessment will begin with demographic information then health literacy, depression and anxiety and physical activity level will evaluation with related questionnaires.
- Conditions
- Cystic Fibrosis
- Being tested
- Assessments
- Medical subject headings
- Cystic Fibrosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AssessmentsOther
Health literacy Anxiety and depression Physical activity Adherence to airway clearance techniques
| Study group | Role | What they receive |
|---|---|---|
| Cystic Fibrosis | Inclusion Criteria:
have a confirmed diagnosis of CF stable clinical condition 18-65 ages volunteering to participate
Exclusion Criteria:
having a serious comorbidity that limits mobilization or participation in physical activity being illiterate having cognitive problems being pregnant incomplete answers to surveys Receives: Other: Assessments |
What is being measured
The primary outcome is the main question the study is designed to answer.
Health Literacy
Health literacy will be evaluated with Health Literacy Scale. This scale total score ranges from 25-125 and lower scores show that lower health literacy.
Measured: 5 minutes
Secondary outcomes (3)
Anxiety and Depression
Anxiety and depression will be evaluated with Hospital Anxiety and Depression Scale. A score of 11 or more indicates mood disorders. Anxiety or depression subscales score ranges from 0-21.
Measured: 5 minutes
Physical Activity
Physical activity will be evaluated with International Physical Activity Questionnaire Short Form.
Measured: 3 minutes
Adherence to Airway Clearance Tecniques
Frequency of used airway clearance tecniques for a week
Measured: 1 minute
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jul 2023
- Study start15 Aug 2023
- Primary completion15 Aug 2024
- Study completion15 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cystic FibrosisStudies of the same condition, open and under way.
- More trials run by Hacettepe UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 62 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hacettepe University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aydan Aslı Aksel Uylar, Hacettepe University
- Investigators
- Naciye Vardar Yağlı, Study director, Hacettepe UniversityEbru Damadoğlu, Study chair, Hacettepe UniversityOğuz Karcıoğlu, Study chair, Hacettepe UniversityAydan Aslı Aksel Uylar, Principal investigator, Hacettepe University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05963503
- Sponsor's protocol ID
- GO 22/114
- Status last verified
- Feb 2024
- First submitted
- 19 Jul 2023
- Last updated
- 13 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predictors of Health Literacy in Adults With Cystic Fibrosis
- ClinicalTrials.gov ID
- NCT05963503
- Acronym / sponsor ID
- GO 22/114
- Conditions
- Cystic Fibrosis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 62 participants (actual)
- Lead sponsor
- Hacettepe UniversityUniversity, hospital or other
- Study start
- 15 Aug 2023 (actual)
- Primary completion
- 15 Aug 2024 (actual)
- Study completion
- 15 Aug 2025 (actual)
- First posted
- 27 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study investigation of relationship between health literacy and physical activity, anxiety and depression, adherence to airway clearance techniques in adult patients with cystic fibrosis.
Detailed description
The assessment will begin with demographic information then health literacy, depression and anxiety and physical activity level will evaluation with related questionnaires.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Cystic Fibrosis | – | Other: AssessmentsInclusion Criteria: have a confirmed diagnosis of CF stable clinical condition 18-65 ages volunteering to participate Exclusion Criteria: having a serious comorbidity that limits mobilization or participation in physical activity being illiterate having cognitive problems being pregnant incomplete answers to surveys |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Cystic fibrosis participants between 18-65 years old.
Key inclusion criteria (1 listed)
- be between the ages of 18-65 volunteering to participate
Key exclusion criteria (1 listed)
- having any cardiopulmonary disease having cognitive problems being illiterate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AssessmentsHealth literacy Anxiety and depression Physical activity Adherence to airway clearance techniques | Other | Cystic Fibrosis |
Primary outcome
Health Literacy
Time frame: 5 minutes
Health literacy will be evaluated with Health Literacy Scale. This scale total score ranges from 25-125 and lower scores show that lower health literacy.
3 secondary outcomes
Anxiety and Depression
Time frame: 5 minutes
Physical Activity
Time frame: 3 minutes
Adherence to Airway Clearance Tecniques
Time frame: 1 minute
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 May 2026.
Related trials for Cystic Fibrosis
RecruitingPhase 2
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Active, not recruitingObservational study
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
Cystic Fibrosis, Bone Loss
RecruitingObservational study
Natural History of Bronchiectasis
Bronchiectasis, Cystic Fibrosis
RecruitingObservational study
Role of Genetic Factors in the Development of Lung Disease
Cystic Fibrosis, Pulmonary Fibrosis
RecruitingPhase 2
Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.
Cystic Fibrosis - Complete
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Naciye Vardar Yağlı study director
Hacettepe University
Ebru Damadoğlu study chair
Hacettepe University
Oğuz Karcıoğlu study chair
Hacettepe University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cystic Fibrosis, run by Hacettepe University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Health Literacy (time frame: 5 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.